273 related articles for article (PubMed ID: 21875902)
21. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
22. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.
Al-Ahmadi W; Al-Ghamdi M; Al-Souhibani N; Khabar KS
J Pathol; 2013 May; 230(1):28-38. PubMed ID: 23401122
[TBL] [Abstract][Full Text] [Related]
23. Tristetraprolin Recruits Eukaryotic Initiation Factor 4E2 To Repress Translation of AU-Rich Element-Containing mRNAs.
Tao X; Gao G
Mol Cell Biol; 2015 Nov; 35(22):3921-32. PubMed ID: 26370510
[TBL] [Abstract][Full Text] [Related]
24. Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNA-destabilizing proteins, KSRP and TTP.
Bhattacharyya S; Kumar P; Tsuchiya M; Bhattacharyya A; Biswas R
Biochem Biophys Res Commun; 2013 Apr; 433(4):484-8. PubMed ID: 23524258
[TBL] [Abstract][Full Text] [Related]
25. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.
Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW
Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973
[TBL] [Abstract][Full Text] [Related]
26. Tristetraprolin: a novel mediator of the anticancer properties of resveratrol.
Li C; Tang C; He G
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323060
[TBL] [Abstract][Full Text] [Related]
27. Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteins.
Griseri P; Pagès G
J Interferon Cytokine Res; 2014 Apr; 34(4):242-54. PubMed ID: 24697202
[TBL] [Abstract][Full Text] [Related]
28. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA.
Kim CW; Kim HK; Vo MT; Lee HH; Kim HJ; Min YJ; Cho WJ; Park JW
Biochem Biophys Res Commun; 2010 Sep; 400(1):46-52. PubMed ID: 20691152
[TBL] [Abstract][Full Text] [Related]
29. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts.
Lai WS; Parker JS; Grissom SF; Stumpo DJ; Blackshear PJ
Mol Cell Biol; 2006 Dec; 26(24):9196-208. PubMed ID: 17030620
[TBL] [Abstract][Full Text] [Related]
30. Tristetraprolin is involved in the glucocorticoid-mediated interleukin 8 repression.
Shi JX; Li JS; Hu R; Shi Y; Su X; Guo XJ; Li XM
Int Immunopharmacol; 2014 Oct; 22(2):480-5. PubMed ID: 25111853
[TBL] [Abstract][Full Text] [Related]
31. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages.
Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ
Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257
[TBL] [Abstract][Full Text] [Related]
32. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.
Chen W; Wei F; Xu J; Wang Y; Chen L; Wang J; Guan X
Int J Mol Med; 2011 Dec; 28(6):985-91. PubMed ID: 21887460
[TBL] [Abstract][Full Text] [Related]
33. HuR post-transcriptionally regulates TNF-α-induced IL-6 expression in human pulmonary microvascular endothelial cells mainly via tristetraprolin.
Shi JX; Su X; Xu J; Zhang WY; Shi Y
Respir Physiol Neurobiol; 2012 Apr; 181(2):154-61. PubMed ID: 22426177
[TBL] [Abstract][Full Text] [Related]
34. Tristetraprolin regulates the stability of HIF-1alpha mRNA during prolonged hypoxia.
Kim TW; Yim S; Choi BJ; Jang Y; Lee JJ; Sohn BH; Yoo HS; Yeom YI; Park KC
Biochem Biophys Res Commun; 2010 Jan; 391(1):963-8. PubMed ID: 19962963
[TBL] [Abstract][Full Text] [Related]
35. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells.
Lin NY; Lin CT; Chang CJ
Biochem Biophys Res Commun; 2008 Jan; 365(1):69-74. PubMed ID: 17971298
[TBL] [Abstract][Full Text] [Related]
36. Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts.
du Manoir JM; Francia G; Man S; Mossoba M; Medin JA; Viloria-Petit A; Hicklin DJ; Emmenegger U; Kerbel RS
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):904-16. PubMed ID: 16467105
[TBL] [Abstract][Full Text] [Related]
37. Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins.
Hitti E; Bakheet T; Al-Souhibani N; Moghrabi W; Al-Yahya S; Al-Ghamdi M; Al-Saif M; Shoukri MM; Lánczky A; Grépin R; Győrffy B; Pagès G; Khabar KS
Cancer Res; 2016 Jul; 76(14):4068-80. PubMed ID: 27197193
[TBL] [Abstract][Full Text] [Related]
38. The role of RNA-binding protein tristetraprolin in cancer and immunity.
Guo J; Qu H; Chen Y; Xia J
Med Oncol; 2017 Nov; 34(12):196. PubMed ID: 29124478
[TBL] [Abstract][Full Text] [Related]
39. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
Mahmoud L; Moghrabi W; Khabar KSA; Hitti EG
RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
[TBL] [Abstract][Full Text] [Related]
40. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
